Videos
About Us
GSK is a science led global healthcare company with a special purpose to help people do more, feel better, live longer. Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. We have world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines and vaccines……
Follow Us
Our Testimonial
My father and my uncle began their career and retired from Glaxo India. For this reason, I have had an emotional bond with GSK from when I was a child. I never thought that I would work for one company for 12 years and this alone is a proud achievement to me.
GSK’s patient focus gives me a deep sense of fulfilment in my job. At the moment, I work on Veeva, a Customer Relationship Management tool, which will go live in India from 1 September 2016. Veeva is the biggest change to happen in GSK to the way we engage healthcare professionals (HCPs). More than three decades ago, Glaxo innovated with Visual Aids to detail to HCPs and we are now embracing digital technology. It’s exciting times ahead.
As a young management graduate, I was impressed by GSK’s Future Leader Programme, where emphasis was laid on learning from grassroots. There was no shortcut to the top, but once you worked hard on something , there was no holding you back either. The different roles in which I worked gave me a strong foundation of competencies, ranging from sales excellence to people management.
My proudest moment in GSK was when I was selected for the Fast-track Career Programme. I was one of three selected from the field, trained and given opportunities to rotate through the business.
I feel great when I see the initial look of surprise and then awe when I tell people I work for GSK. The reaction usually is “Oh wow, you work at Glas-co/Galaxo/Glaxco (‘Glaxo’ is usually mispronounced in India- GSK is easier to say).”
Jobs
Key achievements
Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. The values on which the Group was founded have always inspired growth for us and this is manifest in our achievements over the years.
Key achievements are listed below –
GSK India recognised as a “Best Healthcare Brand” at The Economic Times Best Healthcare Brands 2016
Read more
GSK India was recognised by “The Economic Times Best Healthcare Brands 2016” in the pharmaceutical category. A. Vaidheesh, Vice President, South Asia and Managing Director, India, accepted the recognition on June 27, 2016 from J.P. Nadda, Union Minister of Health and Family Welfare and Jagdish Prasad, Director General of Health Services in New Delhi.
In continuation to ET’s series of Best Brands across sectors, ET conducted “The Economic Times Best Healthcare Brands 2016” for the first time. This is an initiative to bring together and recognize brands which symbolize quality, status and trust and are accepted as reliable brands.
GSK wins The Economic Times Supply Chain award
Read more
GlaxoSmithKline Pharmaceuticals was felicitated at The Economic Times 3rd Annual Supply Chain Management Summit 2016 for exemplary supply chain management and logistics. The Economic Times awarded States and private companies, at the Summit at The Leela, Mumbai on June 24, 2016.
Raju Krishnaswamy, Regional Supply Chain Head, South Asia, GSK Pharmaceuticals, accepted the award on behalf of the company from Babul Supriyo, Honourable Union Minister of Urban Development, and for Housing and Urban Poverty Alleviation. Also felicitated at the event were the Transport Ministers of the States of Rajasthan and Karnataka. Among the private companies who won the award were Sanofi, Britannia, Colgate Palmolive, Marico and Parle Agro and Hindalco.
The Economic Times Editorial had earlier shortlisted various organisations that stand out from their contemporaries in Supply Chain practices and it is a proud moment that GSK has been recognised for its best-in-class supply chain practices.
Ranked 2nd in the pharmaceuticals sector in the ‘Most Respected Companies’ in India by Businessworld
Adjudged as one of India’s Most Admired Companies by Fortune India
GSK ranked 39th on D&I rankings worldwide
Read more
Thomson Reuters D&I Index Ranks the 2018 Top 100 Most Diverse & Inclusive Organizations Globally
D&I Index measures relative performance against multiple factors that define diverse and inclusive workplaces
The Matterhorn Group at Morgan Stanley was the first advisory team to effectively use the, now 3-year old, D&I Index as an investment tool
NEW YORK/LONDON, September 6, 2018 – Thomson Reuters today announced the 2018 top 100 most diverse and inclusive organizations globally as ranked by the Diversity & Inclusion (D&I) Index. The D&I Index demonstrates Thomson Reuters vision of delivering news, information and analytics to the global financial and corporate communities. The index ratings are informed by Thomson Reuters environmental, social, and governance (ESG) data, designed to transparently and objectively measure the relative performance of more than 7,000 companies and provide clients with differentiated insight.
This year, 52 new companies earned a top 100 spot on the index, while 17 companies remained ranked on the index for 2 consecutive years, and 12 companies regained a spot on the index.
The D&I Index is available on Thomson Reuters Eikon, as are the underlying diversity and inclusion metrics, which can be used to help financial professionals screen companies for long-term opportunities and risks in their investments, as well as empower gender lens investing strategies. Each company is assigned a score across Diversity, Inclusion, People Development and News Controversy pillars. Only companies with scores across all four pillars are assigned an overall score (the average of the pillar scores). The top 100 ranked companies with the best overall scores are selected for the Index.
“Our Diversity and Inclusion index, now in its third year, highlights the companies who are leading the way in imbedding Diversity & Inclusion into their company strategy,” said Elena Philipova, global head of ESG (Environmental, Social and Governance) at Thomson Reuters, Financial & Risk. “The industry is beginning to recognize the societal and business benefits of investing in diverse and inclusive companies and we are working closely with various investment firms who are looking to develop investable products based on our D&I index. We remain committed to providing industry-leading ESG data to help investors make smarter investment decisions.”
The D&I index continues to receive recognition from industry analysts across the globe:
Virginie O’Shea, research director at Aite Group, commented: “The topic of diversity has continued to dominate industry mindshare in 2018. Not only have firms been increasing their corporate disclosure with the intent of improving corporate governance and transparency, regulators have also been compelling change and 2019 will see the introduction of the second Shareholder Rights Directive in Europe to this end. Investors are keen to see much more data related to topics such as diversity to factor these into their ESG strategies, which have been gathering pace over the last 12 months.”
Will Jan, Vice President & Lead Analyst at Outsell, commented: “Recent studies have revealed that diversity & inclusion is correlated to value-creation & profitability. As such, financial services have an obligation to inform investors of these opportunities.”
Brad Bailey, research director, capital markets at Celent, commented: “With growth in ESG investing coming from more and more quarters, it is crucial to have transparent benchmarks for all types of portfolio managers (PMs) and investors, from long only to quantitative funds, to ensure that they have a clear framework for the effective allocation of resources into companies with the most astute approaches to diversity.”
“At Thomson Reuters, we understand that focusing on total societal impact is fundamental to driving long-term financial success,” said Patsy Doerr, global head of corporate responsibility and inclusion at Thomson Reuters. “Creating the workforce of the future means building diverse teams which attract the best and brightest from around the world. The D&I Index helps investors and analysts identify the companies that are getting this right, helping them to make investment decisions that align with their values and the bottom line.”
The D&I Index, launched in 2016, ranks the top 100 publicly traded companies globally with the most diverse and inclusive workplaces, as measured by 24 metrics across four key categories: Diversity, Inclusion, People Development and News Controversies. The Index is then calculated by weighing each metric based on importance in the market and how each company compares with its peers.
People Capital Index (PCI)
Read more
GSK ranked among the 50 best companies in India as per People Capital Index (PCI). GSK was conferred this recognition at the HR Leadership Summit 2018.
Through this award, GSK’s HR policies, programmes and initiatives for talent development have been acknowledged as being among the best across Indian enterprise.
Creating shared value
Read more
GSK won the Porter Prize in the category, ‘Creating Shared Value’
GlaxoSmithKline Pharmaceuticals Limited won the Porter Prize in the category, ‘Creating Shared Value’, by the Institute for Competitiveness, a research institute that advises companies and governments on competition and strategy and is the Indian chapter of Institute for Strategy and Competitiveness at Harvard Business School.
GSK India was recognised for its performance and the high impact it has created by its strategic acumen in re-conceiving products and markets, redefining productivity in the value chains, enabling community development and in turn, creating societal and economic progress.